Solventum Co. (NYSE:SOLV) Receives $80.29 Consensus Price Target from Brokerages

Solventum Co. (NYSE:SOLVGet Free Report) has received a consensus recommendation of “Hold” from the eleven ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $80.29.

SOLV has been the subject of several recent research reports. The Goldman Sachs Group upped their target price on Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a report on Monday, March 3rd. Piper Sandler upgraded Solventum from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $78.00 to $87.00 in a research report on Monday, May 19th. Mizuho raised their price objective on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. Morgan Stanley boosted their price objective on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Wednesday, March 5th. Finally, KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a “sector weight” rating on the stock.

View Our Latest Stock Analysis on SOLV

Solventum Stock Down 1.6%

Shares of Solventum stock opened at $74.36 on Monday. The stock’s fifty day moving average is $69.59 and its 200-day moving average is $71.63. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum has a 12-month low of $47.16 and a 12-month high of $85.92. The firm has a market capitalization of $12.86 billion, a PE ratio of 34.42, a price-to-earnings-growth ratio of 1.94 and a beta of 0.54.

Solventum (NYSE:SOLVGet Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $1.34 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.15. The company had revenue of $2.07 billion during the quarter, compared to the consensus estimate of $2.02 billion. The firm’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.08 earnings per share. Equities analysts anticipate that Solventum will post 6.58 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Clarity Asset Management Inc. acquired a new stake in shares of Solventum in the fourth quarter valued at approximately $25,000. Rossby Financial LCC acquired a new position in Solventum during the first quarter worth $25,000. Strengthening Families & Communities LLC increased its holdings in Solventum by 376.8% during the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company’s stock worth $25,000 after buying an additional 260 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in Solventum during the fourth quarter worth $26,000. Finally, Raiffeisen Bank International AG acquired a new position in Solventum during the fourth quarter worth $29,000.

Solventum Company Profile

(Get Free Report

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Further Reading

Analyst Recommendations for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.